Heer Shah

Heer Shah has a Master's degree in Biotechnology from Northeastern University and a Bachelor of Science in Biotechnology from CHARUSAT. They have gained valuable experience in various roles at companies like Ensoma, Sana Biotechnology, Ring Therapeutics, Merck, and Intellia Therapeutics. Their expertise includes genome modification, cell engineering, bioprocess and analytics, and vaccine drug product development. They have also been involved in student leadership roles and volunteer work in the field of biopharmaceutical analysis.